BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home
»
Newsletters
» BioWorld
BioWorld
May 16, 2002
View Archived Issues
Tranzyme Enters QBI Deal, Targets Neurosensory Drugs
Read More
Hyseq, BASF To Finish Deal Early; Hyseq Cutting Employees
Read More
Second-Generation LongSAGE' Strategists Say 15,000 Genes In Human Genome Still Uncounted
Read More
Nexell's Board OKs Orderly Wind-Down' Of Operations
Read More
Other News To Note
Read More
Corixa Wants Dispute Resolution For Bexxar Through FDAMA
Corixa Corp. said it is requesting an appeal of the FDA's complete review letter questioning the net clinical benefit and safety of the company's lead cancer product, known as Bexxar. (BioWorld Today)
Read More
